SCHEMBL10042664

SCHEMBL10042664

c1cc(-n2c3ccccc3c3cc(-c4nnco4)ccc32)cc(-n2c3ccccc3c3cc(-c4nnco4)ccc32)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 12/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TLR8 Q9NR97 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10064524 0.85 NOTUM (0.50) NOTUMKDM4EALDH1A1LMNAMAPT
SCHEMBL29139211 0.83 KDM4E (0.62) NOTUMKDM4EALDH1A1LMNAMAPT
SCHEMBL18352325 0.80 KDM4E (0.57) KDM4EALDH1A1LMNAMAPTHTT
SCHEMBL18468317 0.78 KDM4E (0.55) KDM4EALDH1A1LMNAMAPTHTT
SCHEMBL16102063 0.77 ALDH1A1 (0.48) NOTUMKDM4EALDH1A1MAPTHTT
SCHEMBL23341615 0.77 L3MBTL1 (0.53) KDM4EALDH1A1MAPTHTTATM
SCHEMBL10331647 0.77 L3MBTL1 (0.64) KDM4EALDH1A1MAPTHTTTSHR
SCHEMBL12113746 0.77 L3MBTL1 (0.53) KDM4EALDH1A1MAPTHTTATM
SCHEMBL10042633 0.77 L3MBTL1 (0.64) KDM4EALDH1A1MAPTHTTTSHR
SCHEMBL10042920 0.77 L3MBTL1 (0.53) KDM4EALDH1A1MAPTHTTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8192847-B2 Organic electroluminescent device material, organic electroluminescent device, display and illuminating device KONICA MINOLTA HOLDINGS, INC. (JP) 2012-06-05 — — US disclosed
US-8192847-B2 Organic electroluminescent device material, organic electroluminescent device, display and illuminating device KONICA MINOLTA HOLDINGS, INC. (JP) 2012-06-05 — — US disclosed
US-20090167165-A1 ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-07-02 — — US disclosed
US-20090167165-A1 ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090167165-A1 ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE L1CAM, OR10J3, ICOSLG NOTUM 1037/4885KDM4E 1687/4885ALDH1A1 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback